In the brain of TSC patients, mTOR hyperactivity promotes development of often multifocal brain lesions characterized by aberrant glioneuronal proliferation, cortical dyslamination, and hypomyelination, along with the presence of dysplastic neurons and improperly developed giant cells (4, 27, 45–47). The gene discussed is MTOR; the disease is tuberous sclerosis.